KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Inventory (2016 - 2025)

Boston Scientific (BSX) has disclosed Inventory for 17 consecutive years, with $2.9 billion as the latest value for Q4 2025.

  • Quarterly Inventory rose 4.73% to $2.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.9 billion through Dec 2025, up 4.73% year-over-year, with the annual reading at $2.9 billion for FY2025, 4.73% up from the prior year.
  • Inventory hit $2.9 billion in Q4 2025 for Boston Scientific, up from $2.9 billion in the prior quarter.
  • In the past five years, Inventory ranged from a high of $2.9 billion in Q4 2025 to a low of $1.4 billion in Q1 2021.
  • Historically, Inventory has averaged $2.2 billion across 5 years, with a median of $2.3 billion in 2023.
  • Biggest five-year swings in Inventory: decreased 13.57% in 2021 and later surged 34.45% in 2023.
  • Year by year, Inventory stood at $1.6 billion in 2021, then rose by 15.96% to $1.9 billion in 2022, then skyrocketed by 33.05% to $2.5 billion in 2023, then grew by 13.12% to $2.8 billion in 2024, then increased by 4.73% to $2.9 billion in 2025.
  • Business Quant data shows Inventory for BSX at $2.9 billion in Q4 2025, $2.9 billion in Q3 2025, and $2.9 billion in Q2 2025.